Manning & Napier Disciplined Value Z holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Manning & Napier Disciplined Value Series Class Z MDVZX
- NAV / 1-Day Return $10.33 / −0.48 %
- Fund Size $121.0M
- Adjusted Expense Ratio 0.460%
- Net Expense Ratio 0.450%
- Fee Level: Distribution Below Average
- Share Class Type Institutional
- Morningstar Category Large Value
- Equity Style Box (Funds) Mid Value
- Minimum Initial Investment $1M
- Investment Status Open
- TTM Yield 1.90%
- Turnover Ratio 49%
Morningstar’s Analysis MDVZX
Will MDVZX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 26.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Merck & Co Inc | 4.35 | 5M | Healthcare |
Citigroup Inc | 3.44 | 4M | Financial Services |
Gilead Sciences Inc | 2.94 | 3M | Healthcare |
UnitedHealth Group Inc | 2.51 | 3M | Healthcare |
ConocoPhillips | 2.47 | 3M | Energy |
Qualcomm Inc | 2.41 | 3M | Technology |
Wells Fargo & Co | 2.32 | 3M | Financial Services |
Bristol-Myers Squibb Co | 2.19 | 3M | Healthcare |
ExxonMobil Holdings Corp | 2.12 | 2M | Energy |
Pfizer Inc | 2.07 | 2M | Healthcare |